Exploring medication use by blind patients in Saudi Arabia

Kentab, Basma Y.; Al-Rowiali, Kholuod Z.; Al-Harbi, Rehab A.; Alshammari, Nouf Hayef; Balhareth, Wiam M.; Al-Yazeed, Huda F.

doi:10.1016/j.jsps.2014.05.002

Cited by 22 publications

(41 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of articles identified from database search was as follows: Amed: 188; Cinahl: 42; Embase: 3095; HMIC: 57; Medline: 537; ProQuest: 13; PsycINFO: 72; and Web of Science: 89. After title, abstract and reference list searches, 11 studies were included, of which three were conducted in the UK, two in each of United States and Malaysia and one was conducted in Canada, Saudi Arabia, Japan and Thailand . Three studies included people described as deaf/hard of hearing/hearing‐impaired, and four studies included participants with sight loss .…”

Section: Resultsmentioning

confidence: 99%

“…One study used a case–control design to explore medicines management in older people with sight loss compared with age‐matched controls without sight loss. Five cross‐sectional studies were included, three of which utilised questionnaires that were administered face‐to‐face by researchers as the participants had sight loss . One study used focus groups with deaf and hearing‐impaired participants, whilst another used a pre‐/post design to test the effect of a 2‐hour medical education lecture for deaf and hearing‐impaired participants .…”

Section: Resultsmentioning

confidence: 99%

“…Seven studies explored the pharmaceutical care needs of patients with sight loss. The most common challenges for patients with sight loss in the study conducted in Saudi Arabia were identifying medicines (indicated by 75% of participants), recognising medicine dosages (82%) and identifying expiry dates (92%) . The study in Malaysia identified that reported ease of use varied by dosage form, with liquid preparations and ear/eye drops rated as the most difficult to use .…”

Section: Resultsmentioning

confidence: 99%

“…Three studies identified the role that family members or carers played in facilitating the pharmaceutical care of people with SL . One case–control study found that more older people with sight loss relied on daily help to administer or organise their medicines than age‐matched controls without sight loss.…”

Section: Resultsmentioning

confidence: 99%

“…One case–control study found that more older people with sight loss relied on daily help to administer or organise their medicines than age‐matched controls without sight loss. Over half (52%) of 95 participants in the study from Saudi Arabia received their medication instructions from friends or relatives, and 46% of participants relied on others to use their medicines . Nearly half (46%) of these participants did not consider the service that they received from their pharmacist to be sufficient to enable them to use their medicines in the correct way .…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

A scoping review of the pharmaceutical care needs of people with sensory loss

Killick

Macaden

Smith

et al. 2018

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Objectives This scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL). Methods Electronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated. Key findings Eleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy. Conclusions There is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

A scoping review of the pharmaceutical care needs of people with sensory loss

Killick

Macaden

Smith

et al. 2018

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

show abstract

Analysis of requirements for developing a mobile device‐based medicines management application for people who are blind and visually impaired

Dinari

Bahaadinbeigy

Moulaei

2022

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background People with visual impairments are often faced with challenges in the process of medicines management and use. Mobile device‐based applications can be a potential solution in reducing these challenges. Objectives This study aimed to analyse the requirements for developing a mobile device‐based medicines management application for people who are blind and visually impaired. Methods A questionnaire was designed to examine the requirements for developing a medicines management application for people who were blind and visually impaired. The questionnaire was sent to 2081 people who are blind or visually impaired, and their instructors. Among them, 146 people (125 with visual impairments and 21 instructors) completed the questionnaire. SPSS 23 software was used for statistical analysis. Results Ninety percent of people with visual impairments and 75% of instructors were willing to assist in application design. Out of 44 data elements, 35 were considered important for designing and creating mobile device‐based medicines management applications. ‘Providing education information about drugs in the form of audio files’ (4.71 ± 0.56), ‘Ability to update software’ (4.71 ± 0.56) and ‘Ability to search for physician’s addresses’ (4.71 ± 0.46) were rated highest, in terms of required ‘Application capabilities’, by the study cohort based on average Likert scale scores (1 = very low, 2 = low, 3 = moderate, 4 = high, 5 = very high). Conclusion This study provides a set of data elements that people who are blind and visually impaired, and their instructors, have identified as being important to the development and design of mobile device‐based medicines management applications. Developers can use the identified data elements to help in the design and implementation of their medicines management applications or electronic systems. Applications and electronic systems that incorporate features for people who are blind and visually impaired, have the potential to improve quality of life by enabling independent medicines management and medicines adherence, whilst potentially decreasing medication errors, rate of diseases, frequency of hospitalisations and medicines related deaths.

show abstract

A systematic review of pharmacists’ interventions to support medicines optimisation in patients with visual impairment

et al. 2019

Self Cite

View full text Add to dashboard Cite

Background People with visual impairment often report poorer health and encounter many challenges when using medicines. Pharmacists can play a significant role in optimising medicines use for these patients. However, little is known about pharmacists’ current practices when providing services to this population nor the impact of such services, if any, on medicines optimisation-related outcomes. Aim of the review This systematic review aims to identify the types, and assess the effectiveness of, interventions provided by pharmacists on medicines optimisation-related outcomes. Method Systematic searches of the following electronic databases were carried out from date of inception to March 2018: Cochrane Library; MEDLINE; EMBASE; International Pharmaceutical Abstracts; Scopus; and Cumulative Index to Nursing and Allied Health Literature. Several trial registries and grey literature resources were also searched. Any randomised controlled trials, non-randomised controlled trials, controlled before-and-after studies, or interrupted time series analyses reporting on interventions provided by pharmacists to adult visually impaired patients and/or their caregivers in order to improve medicines optimisation-related outcomes of medicine safety, adherence, patient satisfaction, shared decision making, or quality of life were included. Results A total of 1877 titles/abstracts were screened, and 27 full text articles were assessed for eligibility. On examination of full texts, no studies met the inclusion criteria for this review. Conclusion This review highlights the need for future research that would be vital for promoting the safe and effective use of medicines and the delivery of pharmaceutical care services to people with visual impairment.

show abstract

Exploring medication use by blind patients in Saudi Arabia

Cited by 22 publications

References 10 publications

A scoping review of the pharmaceutical care needs of people with sensory loss

A scoping review of the pharmaceutical care needs of people with sensory loss

Analysis of requirements for developing a mobile device‐based medicines management application for people who are blind and visually impaired

A systematic review of pharmacists’ interventions to support medicines optimisation in patients with visual impairment

Contact Info

Product

Resources

About